BioSpace News Archive

FDA

Amneal Announces Approval and Launch of Clobazam Tablets and Clobazam Oral Suspension

U.S market annual sales for the 12 months ended August 2018 for Clobazam Tablets is estimated to be approximately $594 million and for Clobazam oral suspension is estimated to be approximately $255 million.

October 23, 2018
·
7 min read
Business

ATI Announces Third Quarter 2018 Results

Sales were $1.02 billion, 17% higher than Q3 2017 and in line with Q2 2018

October 23, 2018
·
23 min read
Crop Announces Major 1.5 Million Pound 3-Year Supply Agreement

Crop Infrastructure Corp. announced today that Hempire, the Company’s brand and tenant at its 49% owned Nevada CBD farm, has signed a three-year, 500,000 pound per year (1,500,000 pounds total) supply agreement with deliveries starting August 2019.

October 23, 2018
·
4 min read
Business

3M Reports Third-Quarter 2018 Results

Sales of $8.2 billion, down 0.2 percent year-on-year

October 23, 2018
·
22 min read
Job Trends

Heska to Present at Jefferies 2018 London Healthcare Conference

Heska Corporation announced that Kevin Wilson, Heska’s President & Chief Executive Officer, will present at the Jefferies 2018 London Healthcare Conference on Wednesday, November 14, 2018 at 2 p.m. UTC/GMT in London, UK.

October 23, 2018
·
1 min read
Genetown

New Study Showcases Improved Survival With More Frequent Home Hemodialysis in Incident Dialysis Patients

Patients 20-44 years of age experienced 44% lower risk of death

October 23, 2018
·
5 min read
Pharm Country

Kelyniam Submits Third 510(k) Application

Kelyniam Global, Inc., (KLYG), a maker of patient specific craniofacial and skull implants, announced the submission of its third 510(k) application to the FDA to expand their line of custom implants.

October 23, 2018
·
2 min read
FDA

Sun Pharma Announces the Availability of ILUMYA™ (tildrakizumab-asmn) in the United States for the Treatment of Moderate-to-Severe Plaque Psoriasis

New Insights on the Cost-Effectiveness of ILUMYA™ Presented Today at the Academy of Managed Care Pharmacy Nexus 2018 Meeting

October 23, 2018
·
9 min read
Business

Ablexis Announces Licensing Agreement with Voyager Therapeutics

Ablexis grants rights to Voyager to use the AlivaMab Mouse platform for research, development and potential commercialization of antibodies

October 23, 2018
·
1 min read
Deals

Resonetics Announces Acquisition Of STI Laser Industries

Resonetics, announced today that it has acquired STI Laser Industries, Ltd. (“STI”), based in Or Akiva, Israel, a leading supplier of laser processing, nitinol shape setting and electropolishing, and cleanroom assembly and packaging for the medical device industry.

October 23, 2018
·
3 min read